US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Actinium Pharmaceuticals

1.42

-0.2000-12.35%

Post-market: 1.440.0200+1.41%19:59 EDT

Volume:4.28M

Turnover:6.12M

Market Cap:44.30M

PE:-0.96

High:1.63

Open:1.61

Low:1.42

Close:1.62

Loading ...

Overview Company News Filings

Actinium Pharmaceuticals: Promising Clinical Advancements and Strong Financial Outlook Support Buy Rating

Actinium Pharmaceuticals to Host KOL Investor Call at 8am ET Today to Highlight Revamped Clinical Programs and Expanded Market Opportunities Including Newly Initiated Actimab-A Solid Tumor Program

Eckert & Ziegler To Supply Actinium Pharmaceuticals With AC-225 For Comprehensive Development Activities

Actinium Pharmaceuticals Signs Actinium-225 Supply Deal With Eckert & Ziegler

MT Newswires Live

BRIEF-Actinium Pharmaceuticals Announces Supply Agreement With Eckert & Ziegler For AC-225 Radioisotope To Support Comprehensive Development Activities

Actinium Pharmaceuticals Announces Supply Agreement With Eckert & Ziegler for Ac-225 Radioisotope to Support Comprehensive Development Activities

THOMSON REUTERS

Actinium Pharmaceuticals Announces Supply Agreement with Eckert & Ziegler for Ac-225 Radioisotope to Support Comprehensive Development Activities

Actinium Pharmaceuticals Announces Research Collaboration With Memorial Sloan Kettering to Support Further Clinical Expansion of Actimab-a's Backbone Therapy Strategy

THOMSON REUTERS

Actinium Pharmaceuticals to Host Investor Kol Call With DR. Ehab Atallah of the Medical College of Wisconsin and Provide a Pipeline Update Highlighting Revamped Clinical Programs and Expanded Market Opportunities for Actimab-a and Iomab-Act With Clinical Data in 2H:2025

THOMSON REUTERS

Actinium Pharmaceuticals to Host Investor KOL Call with Dr. Ehab Atallah of the Medical College of Wisconsin and Provide a Pipeline Update Highlighting Revamped Clinical Programs and Expanded Market Opportunities for Actimab-A and Iomab-ACT with Clinical Data in 2H:2025

Promising Phase 1b Trial Results for Actinium Pharmaceuticals’ Actimab-A in r/r AML Support Buy Rating

Actinium Pharmaceuticals Price Target Maintained With a $4.00/Share by HC Wainwright & Co.

H.C. Wainwright Sticks to Their Buy Rating for Actinium Pharmaceuticals (ATNM)

Actinium Pharmaceuticals: Strategic Clinical Advancements and Innovative Trials Drive Buy Rating

Actinium Pharmaceuticals Launches Clinical Program to Evaluate Actimab-A as Combination Cancer Therapy

MT Newswires Live

Actinium Pharmaceuticals Announces Clinical Trial Program in Solid Tumors Combining Actimab-a With Pd-1 Checkpoint Inhibitors Keytruda® and Opdivo®

THOMSON REUTERS

Actinium Pharmaceuticals Inc - Clinical Proof of Concept Data Expected in 2025

THOMSON REUTERS

Actinium Pharmaceuticals Announces Clinical Trial Program in Solid Tumors Combining Actimab-A with PD-1 Checkpoint Inhibitors KEYTRUDA® and OPDIVO®

Actinium Pharmaceuticals reports Actimab-A + CLAG-M trial results

Actinium Pharmaceuticals Announces Publication of Actimab-A + CLAG-M Trial Results in Patients with Relapsed or Refractory Acute Myeloid Leukemia in the Peer-Reviewed Journal Leukemia

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ATNM/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ATNM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ATNM\",,,,,undefined,":{"symbol":"ATNM","market":"US","secType":"STK","nameCN":"Actinium Pharmaceuticals","latestPrice":1.42,"timestamp":1751054400000,"preClose":1.62,"halted":0,"volume":4276851,"hourTrading":{"tag":"盘后","latestPrice":1.44,"preClose":1.42,"latestTime":"19:59 EDT","volume":1043979,"amount":1482916.4577,"timestamp":1751068751334},"delay":0,"floatShares":31037749,"shares":31195891,"eps":-1.472972,"marketStatus":"Market Closed","change":-0.2,"latestTime":"06-27 16:00:00 EDT","open":1.61,"high":1.63,"low":1.42,"amount":6118958.7276309,"amplitude":0.12963,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.472972,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1751270400000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"AMEX","adjPreClose":1.62,"preHourTrading":{"tag":"盘前","latestPrice":1.66,"preClose":1.6,"latestTime":"08:56 EDT","volume":1610,"amount":2672.6,"timestamp":1751029019873},"postHourTrading":{"tag":"盘后","latestPrice":1.44,"preClose":1.42,"latestTime":"19:59 EDT","volume":1043979,"amount":1482916.4577,"timestamp":1751068751334},"volumeRatio":12.745272112213552,"impliedVol":1.1872,"impliedVolPercentile":0.884},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ATNM\",,,,,undefined,":{"symbol":"ATNM","floatShares":31037749,"roa":"-39.14%","roe":"-130.87%","lyrEps":-1.271797,"volumeRatio":12.745272112213552,"shares":31195891,"dividePrice":0,"high":1.63,"amplitude":0.12963,"preClose":1.62,"low":1.42,"week52Low":1.0292,"pbRate":"1.72","psRate":"546.89","week52High":8.64,"institutionHeld":0,"latestPrice":1.42,"eps":-1.472972,"divideRate":0,"volume":4276851,"delay":0,"ttmEps":-1.472972,"open":1.61,"prevYearClose":1.26,"prevWeekClose":1.5,"prevMonthClose":1.54,"prevQuarterClose":1.61,"fiveDayClose":1.5,"twentyDayClose":1.58,"sixtyDayClose":1.49},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ATNM\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2522885383","title":"Actinium Pharmaceuticals: Promising Clinical Advancements and Strong Financial Outlook Support Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2522885383","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522885383?lang=en_us&edition=fundamental","pubTime":"2025-03-25 23:45","pubTimestamp":1742917531,"startTime":"0","endTime":"0","summary":"Joseph Pantginis, an analyst from H.C. Wainwright, reiterated the Buy rating on Actinium Pharmaceuticals (ATNM – Research Report). The associated p...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/actinium-pharmaceuticals-promising-clinical-advancements-and-strong-financial-outlook-support-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/actinium-pharmaceuticals-promising-clinical-advancements-and-strong-financial-outlook-support-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ATNM"],"gpt_icon":0},{"id":"2522022501","title":"Actinium Pharmaceuticals to Host KOL Investor Call at 8am ET Today to Highlight Revamped Clinical Programs and Expanded Market Opportunities Including Newly Initiated Actimab-A Solid Tumor Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2522022501","media":"PR Newswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522022501?lang=en_us&edition=fundamental","pubTime":"2025-03-25 18:00","pubTimestamp":1742896800,"startTime":"0","endTime":"0","summary":"- Actinium will present 3 separate multi-billion-dollar market opportunities for Actimab-A and Iomab-ACT in myeloid malignancies, solid tumors and cell & gene therapy conditioning. - Dr. Ehab Atallah, Professor of Medicine at the Medical College of Wisconsin to highlight Actimab-A clinical results, mutation agnostic mechanism and backbone therapy potential. - Clinical proof of concept data from frontline AML trial under NCI CRADA, Actimab-A solid tumor program with PD-1 checkpoint inhibitors and Iomab-ACT commercial CAR-T trial together with other expected 2025 milestones to be outlined. - Actinium to highlight manufacturing infrastructure development activity to support revitalized clinical programs. Actinium's company update will highlight the 3 separate potential multi-billion-dollar blockbuster market opportunities being pursued with its targeted radiotherapies including the following:. - Actimab-A as a mutation agnostic, backbone therapy for myeloid malignancies including AML and ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/actinium-pharmaceuticals-host-kol-investor-100000655.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/actinium-pharmaceuticals-host-kol-investor-100000655.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4161","BK4588","HMA","BK4139","BK4144","CR","HST","NCI","ET","BK4585","BK4561","KOL","BK4181","BK4581","BK4218","BK4590","ATNM","BK4202"],"gpt_icon":0},{"id":"2522136140","title":"Eckert & Ziegler To Supply Actinium Pharmaceuticals With AC-225 For Comprehensive Development Activities","url":"https://stock-news.laohu8.com/highlight/detail?id=2522136140","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522136140?lang=en_us&edition=fundamental","pubTime":"2025-03-25 16:50","pubTimestamp":1742892633,"startTime":"0","endTime":"0","summary":"March 25 (Reuters) - ECKERT & ZIEGLER SE ::*TO SUPPLY ACTINIUM PHARMACEUTICALS WITH AC-225 FOR COMPREHENSIVE DEVELOPMENT ACTIVITIES*ACTINIUM PHARMACEUTICALS TO FURTHER DEVELOP ACTIMAB-A AS WELL AS ADD","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nRSD31qW4p:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATNM","BK4139"],"gpt_icon":0},{"id":"2522085623","title":"Actinium Pharmaceuticals Signs Actinium-225 Supply Deal With Eckert & Ziegler","url":"https://stock-news.laohu8.com/highlight/detail?id=2522085623","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522085623?lang=en_us&edition=fundamental","pubTime":"2025-03-25 05:31","pubTimestamp":1742851892,"startTime":"0","endTime":"0","summary":"Actinium Pharmaceuticals  said Monday it signed a supply agreement with Eckert & Ziegler for Actinium-225.Financial details weren't disclosed.Under the agreement, Actinium Pharmaceuticals will access Eckert & Ziegler's high-quality Actinium-225 to advance Actimab-A and other development candidates for US and international clinical trials.Ac-225 targeted radiotherapy offers precise cancer treatment by delivering high-energy alpha particles with minimal penetration. Actimab-A is an Ac-225-based therapy that specifically targets CD33, a receptor overexpressed in acute myeloid leukemia and other myeloid disorders, the company said.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ATNM","BK4139"],"gpt_icon":0},{"id":"2522088515","title":"BRIEF-Actinium Pharmaceuticals Announces Supply Agreement With Eckert & Ziegler For AC-225 Radioisotope To Support Comprehensive Development Activities","url":"https://stock-news.laohu8.com/highlight/detail?id=2522088515","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522088515?lang=en_us&edition=fundamental","pubTime":"2025-03-25 04:46","pubTimestamp":1742849215,"startTime":"0","endTime":"0","summary":"BRIEF-Actinium Pharmaceuticals Announces Supply Agreement With Eckert & Ziegler For AC-225 Radioisotope To Support Comprehensive Development ActivitiesMarch 24 (Reuters) - Actinium Pharmaceuticals Inc","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250324:nTUA5S7C27:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATNM","BK4139"],"gpt_icon":0},{"id":"2522707408","title":"Actinium Pharmaceuticals Announces Supply Agreement With Eckert & Ziegler for Ac-225 Radioisotope to Support Comprehensive Development Activities","url":"https://stock-news.laohu8.com/highlight/detail?id=2522707408","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522707408?lang=en_us&edition=fundamental","pubTime":"2025-03-25 04:15","pubTimestamp":1742847302,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250324:nTUA5S7C27:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ATNM","BK4139"],"gpt_icon":0},{"id":"2522707005","title":"Actinium Pharmaceuticals Announces Supply Agreement with Eckert & Ziegler for Ac-225 Radioisotope to Support Comprehensive Development Activities","url":"https://stock-news.laohu8.com/highlight/detail?id=2522707005","media":"PR Newswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522707005?lang=en_us&edition=fundamental","pubTime":"2025-03-25 04:15","pubTimestamp":1742847300,"startTime":"0","endTime":"0","summary":"NEW YORK, March 24, 2025 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. , a pioneer in the development of targeted radiotherapies,today announced it has entered into an agreement for the supply of Actinium-225  with Eckert & Ziegler. Under this agreement, Actinium Pharmaceuticals will have access to Eckert & Ziegler's high-quality Actinium-225 to further develop its lead product Actimab-A as well as additional early and late-stage development candidates for both U.S. and international clinical trials.Targeted radiotherapies using Ac-225 have shown great promise in the treatment of cancer. The radioisotope releases powerful alpha particles with high energy and low penetration depth, enabling precise targeting of tumor cells, including hard-to-reach micrometastases, while minimizing effects on surrounding healthy tissue. Actimab-A is an Ac-225 based radiotherapy agent, directed against CD33, a receptor overexpressed in patients with acute myeloid leukemia  and other myeloid indications.E","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/actinium-pharmaceuticals-announces-supply-agreement-201500023.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/actinium-pharmaceuticals-announces-supply-agreement-201500023.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ATNM","CR","BK4139","BK4161","HMA","BK4202","NCI"],"gpt_icon":0},{"id":"2520645316","title":"Actinium Pharmaceuticals Announces Research Collaboration With Memorial Sloan Kettering to Support Further Clinical Expansion of Actimab-a's Backbone Therapy Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2520645316","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520645316?lang=en_us&edition=fundamental","pubTime":"2025-03-20 20:00","pubTimestamp":1742472019,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250320:nTUABNGQD3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ATNM"],"gpt_icon":0},{"id":"2520318936","title":"Actinium Pharmaceuticals to Host Investor Kol Call With DR. Ehab Atallah of the Medical College of Wisconsin and Provide a Pipeline Update Highlighting Revamped Clinical Programs and Expanded Market Opportunities for Actimab-a and Iomab-Act With Clinical Data in 2H:2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2520318936","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520318936?lang=en_us&edition=fundamental","pubTime":"2025-03-19 20:30","pubTimestamp":1742387406,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250319:nTUAQ38BR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ATNM","BK4139"],"gpt_icon":0},{"id":"2520927182","title":"Actinium Pharmaceuticals to Host Investor KOL Call with Dr. Ehab Atallah of the Medical College of Wisconsin and Provide a Pipeline Update Highlighting Revamped Clinical Programs and Expanded Market Opportunities for Actimab-A and Iomab-ACT with Clinical Data in 2H:2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2520927182","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520927182?lang=en_us&edition=fundamental","pubTime":"2025-03-19 20:30","pubTimestamp":1742387400,"startTime":"0","endTime":"0","summary":"-  Actinium to highlight 3 separate multi-billion-dollar market opportunities for Actimab-A and Iomab-ACT in myeloid malignancies, solid tumors and cell & gene therapy conditioning. -  Clinical proof of concept data expected in 2H:2025 from Actimab-A combination with blockbuster immunotherapies KEYTRUDA and OPDIVO in solid tumor indications. - Actimab-A expanded into frontline AML in triplet combination with Venetoclax and ASTX-727, Taiho Oncology's hypomethylating agent, under NCI CRADA with initial clinical data expected by year-end 2025. - Iomab-ACT commercial CAR-T trial to initiate patient enrollment with clinical proof of concept data expected in 2H:2025; Iomab-ACT sickle cell disease trial expected to initiate in 1H:2025. Actimab-A as a mutation agnostic, backbone therapy for myeloid malignancies including AML and myelodysplastic syndromes  across multiple treatment settings. Sandesh Seth, Actinium's Chairman and CEO, said, \"We have made significant progress across our pipeline ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/actinium-pharmaceuticals-host-investor-kol-123000877.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/actinium-pharmaceuticals-host-investor-kol-123000877.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","BK4161","HMA","NCI","BK4139","BK4181","BK4202","CR","HST","BK4218","BK4588","ACT","KOL","ATNM"],"gpt_icon":0},{"id":"2520183732","title":"Promising Phase 1b Trial Results for Actinium Pharmaceuticals’ Actimab-A in r/r AML Support Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2520183732","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520183732?lang=en_us&edition=fundamental","pubTime":"2025-03-19 19:56","pubTimestamp":1742385377,"startTime":"0","endTime":"0","summary":"Maxim Group analyst Jason McCarthy has maintained their bullish stance on ATNM stock, giving a Buy rating on March 17. Jason McCarthy’s rating is b...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-phase-1b-trial-results-for-actinium-pharmaceuticals-actimab-a-in-r-r-aml-support-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-phase-1b-trial-results-for-actinium-pharmaceuticals-actimab-a-in-r-r-aml-support-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ATNM"],"gpt_icon":0},{"id":"2520798955","title":"Actinium Pharmaceuticals Price Target Maintained With a $4.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2520798955","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520798955?lang=en_us&edition=fundamental","pubTime":"2025-03-19 01:07","pubTimestamp":1742317620,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ATNM/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 18, 2025 13:07 ET (17:07 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATNM"],"gpt_icon":0},{"id":"2520605043","title":"H.C. Wainwright Sticks to Their Buy Rating for Actinium Pharmaceuticals (ATNM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2520605043","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520605043?lang=en_us&edition=fundamental","pubTime":"2025-03-18 22:05","pubTimestamp":1742306716,"startTime":"0","endTime":"0","summary":"In a report released today, Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Actinium Pharmaceuticals (ATNM – Research Report), wit...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-sticks-to-their-buy-rating-for-actinium-pharmaceuticals-atnm-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-sticks-to-their-buy-rating-for-actinium-pharmaceuticals-atnm-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ATNM"],"gpt_icon":0},{"id":"2520605014","title":"Actinium Pharmaceuticals: Strategic Clinical Advancements and Innovative Trials Drive Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2520605014","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520605014?lang=en_us&edition=fundamental","pubTime":"2025-03-18 22:05","pubTimestamp":1742306712,"startTime":"0","endTime":"0","summary":"Actinium Pharmaceuticals (ATNM – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Joseph Pant...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/actinium-pharmaceuticals-strategic-clinical-advancements-and-innovative-trials-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/actinium-pharmaceuticals-strategic-clinical-advancements-and-innovative-trials-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ATNM"],"gpt_icon":0},{"id":"2520759066","title":"Actinium Pharmaceuticals Launches Clinical Program to Evaluate Actimab-A as Combination Cancer Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2520759066","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520759066?lang=en_us&edition=fundamental","pubTime":"2025-03-18 20:37","pubTimestamp":1742301422,"startTime":"0","endTime":"0","summary":"Actinium Pharmaceuticals  said Tuesday it is launching a clinical program consisting of trials studying Actimab-A in combination with either Merck's  Keytruda or Bristol Myers Squibb's  Opdivo for the treatment of multiple solid tumors.Actimab-A is meant to improve the efficacy of the immunotherapies by targeting myeloid derived suppressor cells, the company said.The Actimab-A trials will include several controlled, head-to-head studies that will evaluate the combination of Actimab-A with Keytruda and Opdivo in comparison with the two drugs alone.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","LU0225771236.USD","LU1989772840.SGD","LU0965509101.SGD","LU2242646821.SGD","IE00BFXG1179.USD","IE00BLSP4239.USD","LU0321505439.SGD","LU1430594728.SGD","LU0203345920.USD","LU1585245621.USD","LU2360032135.SGD","SG9999014575.USD","LU1670710661.SGD","LU1670710588.SGD","LU0234572021.USD","LU1261432733.SGD","LU1116320901.HKD","LU0321505868.SGD","SG9999002232.USD","SGXZ57979304.SGD","LU2461242641.AUD","LU1868836591.USD","LU2106854487.HKD","LU1066051225.USD","LU1037948897.HKD","BK4588","SG9999002224.SGD","LU1934455863.HKD","LU2112291526.USD","IE0002141913.USD","LU1066053197.SGD","BK4581","BMY","IE00BFTCPJ56.SGD","SG9999015341.SGD","LU1069347547.HKD","BK4532","LU2133065610.SGD","LU0237698245.USD","MRK","LU0061475181.USD","ATNM","LU1974910355.USD","LU2324357040.USD","LU0114720955.EUR","LU0203347892.USD","LU1934455277.USD","IE00BN8TJ469.HKD","LU1983299246.USD"],"gpt_icon":0},{"id":"2520627921","title":"Actinium Pharmaceuticals Announces Clinical Trial Program in Solid Tumors Combining Actimab-a With Pd-1 Checkpoint Inhibitors Keytruda® and Opdivo®","url":"https://stock-news.laohu8.com/highlight/detail?id=2520627921","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520627921?lang=en_us&edition=fundamental","pubTime":"2025-03-18 20:00","pubTimestamp":1742299221,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250318:nTUA26DHRZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ATNM"],"gpt_icon":0},{"id":"2520562713","title":"Actinium Pharmaceuticals Inc - Clinical Proof of Concept Data Expected in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2520562713","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520562713?lang=en_us&edition=fundamental","pubTime":"2025-03-18 20:00","pubTimestamp":1742299221,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250318:nTUA26DHRZ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ATNM"],"gpt_icon":0},{"id":"2520784126","title":"Actinium Pharmaceuticals Announces Clinical Trial Program in Solid Tumors Combining Actimab-A with PD-1 Checkpoint Inhibitors KEYTRUDA® and OPDIVO®","url":"https://stock-news.laohu8.com/highlight/detail?id=2520784126","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520784126?lang=en_us&edition=fundamental","pubTime":"2025-03-18 20:00","pubTimestamp":1742299200,"startTime":"0","endTime":"0","summary":"- Trials are designed to demonstrate whether the addition of Actimab-A to either KEYTRUDA or OPDIVO can result in improved patient outcomes. - MDSCs – Myeloid Derived Suppressor Cells in the tumor microenvironment are believed to reduce effectiveness of PD-1 inhibitors like KEYTRUDA and OPDIVO. - Trials supported by preclinical data showing Actimab-A can selectively target and deplete MDSCs which express CD33. - Clinical proof of concept data expected in 2025 could potentially open up a multi-billion-dollar market opportunity for Actimab-A as a combination therapy with PD-1 inhibitors in multiple solid tumors. Actimab-A is Actinium's lead radiotherapeutic that delivers Actinium-225, a potent alpha-emitter radioisotope payload that can produce lethal double strand DNA br","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/actinium-pharmaceuticals-announces-clinical-trial-120000511.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/actinium-pharmaceuticals-announces-clinical-trial-120000511.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1989772840.SGD","LU2023250504.SGD","LU1057294990.SGD","LU2023250843.SGD","LU0985320562.USD","LU0266013472.USD","LU0965509283.SGD","SG9999014542.SGD","LU1941712348.USD","LU1037948897.HKD","SG9999013999.USD","LU1989772923.USD","LU1941712264.USD","LU1989771016.USD","ATNM","LU1037948541.HKD","SG9999002232.USD","IE0009355771.USD","LU1974910355.USD","LU2324357040.USD","LU0289739699.SGD","LU1934455194.USD","BK4202","LU1934455277.USD","SGXZ57979304.SGD","IE00BFTCPJ56.SGD","LU1929549753.HKD","LU1169589451.USD","LU1699723380.USD","LU1116320737.USD","IE0002141913.USD","NCI","SG9999015358.SGD","HMA","LU1093756325.SGD","SG9999002224.SGD","LU0320765646.SGD","LU1983299246.USD","SG9999001176.SGD","IE00BJJMRZ35.SGD","MRK","LU0965509101.SGD","LU1116320901.HKD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","PD","BK4023","SG9999015341.SGD","IE00B4R5TH58.HKD","CR"],"gpt_icon":0},{"id":"2520295235","title":"Actinium Pharmaceuticals reports Actimab-A + CLAG-M trial results","url":"https://stock-news.laohu8.com/highlight/detail?id=2520295235","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520295235?lang=en_us&edition=fundamental","pubTime":"2025-03-17 20:59","pubTimestamp":1742216353,"startTime":"0","endTime":"0","summary":"Actinium Pharmaceuticals (ATNM) announced that results from the clinical trial evaluating Actimab-A in combination with the chemotherapy CLAG-M in ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/actinium-pharmaceuticals-reports-actimab-a-clag-m-trial-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/actinium-pharmaceuticals-reports-actimab-a-clag-m-trial-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ATNM"],"gpt_icon":0},{"id":"2520443526","title":"Actinium Pharmaceuticals Announces Publication of Actimab-A + CLAG-M Trial Results in Patients with Relapsed or Refractory Acute Myeloid Leukemia in the Peer-Reviewed Journal Leukemia","url":"https://stock-news.laohu8.com/highlight/detail?id=2520443526","media":"PR Newswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520443526?lang=en_us&edition=fundamental","pubTime":"2025-03-17 20:50","pubTimestamp":1742215800,"startTime":"0","endTime":"0","summary":"- Median Overall Survival of 18.4 months with Actimab-A + CLAG-M in patients with relapsed or refractory AML who received 1 or 2 lines of prior therapy. - Mutation agnostic potential of Actimab-A demonstrated by high rates of Complete Remissions and Measurable Residual Disease Negativity in patients with high-risk features including TP53 mutations and prior Venetoclax treatment. - Actimab-A + CLAG-M combination yielded deep and clinically meaningful responses with expected and manageable safety profile supporting planned pivotal Phase 2/3 trial. 52% of patients in the Actimab-A +CLAG-M trial had TP53 mutations, 56% had prior allogeneic stem cell transplant and 56% of patients had prior Venetoclax therapy. Actimab-A + CLAG-M produced high rates of measurable residual disease negativity  including 75% across all patients, 83.3% in patients with a TP53 mutation and 100% in patients with prior Venetoclax therapy. Dr. Sameem Abedin, Associate Professor of Medicine at the Medical College of ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/actinium-pharmaceuticals-announces-publication-actimab-125000660.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/actinium-pharmaceuticals-announces-publication-actimab-125000660.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NCI","BK4161","BK4097","OS","HMA","BK4202","BK4192","BK4535","BK4539","MCW","BK4139","CR","ATNM"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":46,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ATNM\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-09","symbol":"ATNM","fiscalQuarterEnding":"2025/03","expectedEps":-0.26,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746763200000,"reportTimeType":"post","actualEps":-0.51},{"market":"US","date":"2025-03-31","symbol":"ATNM","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-11-14","symbol":"ATNM","fiscalQuarterEnding":"2024/09","expectedEps":-0.35,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"post","actualEps":-0.37},{"market":"US","date":"2024-08-05","symbol":"ATNM","fiscalQuarterEnding":"2024/06","expectedEps":-0.48,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1722830400000,"reportTimeType":"post","actualEps":-0.38},{"market":"US","date":"2024-04-26","symbol":"ATNM","fiscalQuarterEnding":"2024/03","expectedEps":-0.42,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1714104000000,"reportTimeType":"post","actualEps":-0.31}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ATNM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ATNM\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2,"buy":0.6,"hold":0.2,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":5,"updateTime":1723176000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ATNM\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ATNM","date":"2025-06-27","current":-1.110442,"percent":0.90798,"low":-13.279332,"twenty":-7.267091,"median":-5.417858,"eighty":-2.646159,"high":-0.808203,"avg":-5.15261,"sd":2.522288,"marketCap":50537343},"quantilePoints":[{"date":"2020-07-02","current":-5.665688,"twenty":-3.724693,"median":-2.771834,"eighty":-1.751477,"marketCap":124078563},{"date":"2020-07-10","current":-6.658086,"twenty":-3.747566,"median":-2.771834,"eighty":-1.751477,"marketCap":145812082},{"date":"2020-07-17","current":-7.217437,"twenty":-3.76424,"median":-2.771834,"eighty":-1.751477,"marketCap":158061877},{"date":"2020-07-24","current":-9.597387,"twenty":-3.787582,"median":-2.771834,"eighty":-1.751477,"marketCap":210182776},{"date":"2020-07-31","current":-10.398523,"twenty":-3.7977,"median":-2.771834,"eighty":-1.751477,"marketCap":227727643},{"date":"2020-08-07","current":-7.911092,"twenty":-3.810149,"median":-2.782388,"eighty":-1.751477,"marketCap":173252923},{"date":"2020-08-14","current":-6.205548,"twenty":-3.810149,"median":-2.782388,"eighty":-1.751477,"marketCap":133406880},{"date":"2020-08-21","current":-5.864306,"twenty":-3.810149,"median":-2.782388,"eighty":-1.751477,"marketCap":126070860},{"date":"2020-08-28","current":-5.390359,"twenty":-3.810336,"median":-2.782388,"eighty":-1.751477,"marketCap":115881943},{"date":"2020-09-04","current":-4.66996,"twenty":-3.810336,"median":-2.782388,"eighty":-1.751477,"marketCap":100394790},{"date":"2020-09-11","current":-5.38404,"twenty":-3.810336,"median":-2.782388,"eighty":-1.751477,"marketCap":115746091},{"date":"2020-09-18","current":-6.527832,"twenty":-3.810336,"median":-2.782388,"eighty":-1.751477,"marketCap":140335343},{"date":"2020-09-25","current":-5.820071,"twenty":-3.810336,"median":-2.782388,"eighty":-1.751477,"marketCap":125119894},{"date":"2020-10-02","current":-5.801113,"twenty":-3.817358,"median":-2.782388,"eighty":-1.751477,"marketCap":124712337},{"date":"2020-10-09","current":-6.661177,"twenty":-3.825987,"median":-2.782388,"eighty":-1.751477,"marketCap":143201973},{"date":"2020-10-16","current":-7.571242,"twenty":-3.825987,"median":-2.782388,"eighty":-1.751477,"marketCap":162766569},{"date":"2020-10-23","current":-7.498581,"twenty":-3.825987,"median":-2.782388,"eighty":-1.751477,"marketCap":153256002},{"date":"2020-10-30","current":-6.621088,"twenty":-3.825987,"median":-2.782388,"eighty":-1.751477,"marketCap":135321789},{"date":"2020-11-06","current":-7.604944,"twenty":-3.838273,"median":-2.782388,"eighty":-1.751477,"marketCap":155429846},{"date":"2020-11-13","current":-7.983862,"twenty":-3.86629,"median":-2.782388,"eighty":-1.751477,"marketCap":163174165},{"date":"2020-11-20","current":-7.418809,"twenty":-3.872917,"median":-2.782388,"eighty":-1.751477,"marketCap":151625619},{"date":"2020-11-27","current":-7.438752,"twenty":-3.894185,"median":-2.782388,"eighty":-1.751477,"marketCap":152033214},{"date":"2020-12-04","current":-7.206083,"twenty":-3.922323,"median":-2.782388,"eighty":-1.751477,"marketCap":147277931},{"date":"2020-12-11","current":-7.631535,"twenty":-3.96628,"median":-2.782388,"eighty":-1.751477,"marketCap":155973307},{"date":"2020-12-18","current":-7.538467,"twenty":-4.006239,"median":-2.782388,"eighty":-1.751477,"marketCap":154071193},{"date":"2020-12-24","current":-7.345685,"twenty":-4.008026,"median":-2.782388,"eighty":-1.751477,"marketCap":150131101},{"date":"2020-12-31","current":-5.185189,"twenty":-4.008026,"median":-2.782388,"eighty":-1.751477,"marketCap":105974895},{"date":"2021-01-08","current":-5.477687,"twenty":-4.008026,"median":-2.782388,"eighty":-1.751477,"marketCap":111952966},{"date":"2021-01-15","current":-5.517573,"twenty":-4.031758,"median":-2.782388,"eighty":-1.751477,"marketCap":112768157},{"date":"2021-01-22","current":-5.557459,"twenty":-4.064172,"median":-2.782388,"eighty":-1.751477,"marketCap":113583349},{"date":"2021-01-29","current":-5.238371,"twenty":-4.134343,"median":-2.782388,"eighty":-1.751477,"marketCap":107061817},{"date":"2021-02-05","current":-6.375123,"twenty":-4.17175,"median":-2.782388,"eighty":-1.751477,"marketCap":130294774},{"date":"2021-02-12","current":-6.149102,"twenty":-4.204316,"median":-2.782388,"eighty":-1.751477,"marketCap":125675356},{"date":"2021-02-19","current":-5.856605,"twenty":-4.232345,"median":-2.782388,"eighty":-1.751477,"marketCap":119697285},{"date":"2021-02-26","current":-5.358029,"twenty":-4.260374,"median":-2.782388,"eighty":-1.751477,"marketCap":109507391},{"date":"2021-03-05","current":-5.151951,"twenty":-4.316431,"median":-2.782032,"eighty":-1.751353,"marketCap":105295568},{"date":"2021-03-12","current":-6.102569,"twenty":-4.34446,"median":-2.782032,"eighty":-1.751353,"marketCap":124724299},{"date":"2021-03-19","current":-5.889843,"twenty":-4.65353,"median":-2.782032,"eighty":-1.751353,"marketCap":120376611},{"date":"2021-03-26","current":-5.590697,"twenty":-5.123456,"median":-2.782388,"eighty":-1.751477,"marketCap":114262675},{"date":"2021-04-01","current":-6.982662,"twenty":-5.222416,"median":-2.782388,"eighty":-1.751477,"marketCap":155119842},{"date":"2021-04-09","current":-7.043306,"twenty":-5.251335,"median":-2.782032,"eighty":-1.751353,"marketCap":156467036},{"date":"2021-04-16","current":-6.462861,"twenty":-5.352711,"median":-2.782032,"eighty":-1.751353,"marketCap":143572459},{"date":"2021-04-23","current":-6.783405,"twenty":-5.381497,"median":-2.782032,"eighty":-1.751353,"marketCap":150693345},{"date":"2021-04-30","current":-6.636128,"twenty":-5.41615,"median":-2.782032,"eighty":-1.751353,"marketCap":147421587},{"date":"2021-05-07","current":-6.315584,"twenty":-5.475028,"median":-2.782032,"eighty":-1.751353,"marketCap":140300701},{"date":"2021-05-14","current":-6.548439,"twenty":-5.488323,"median":-2.782032,"eighty":-1.751353,"marketCap":143181621},{"date":"2021-05-21","current":-7.425875,"twenty":-5.488323,"median":-2.782032,"eighty":-1.751353,"marketCap":162366746},{"date":"2021-05-28","current":-7.536708,"twenty":-5.488323,"median":-2.782032,"eighty":-1.751353,"marketCap":164790131},{"date":"2021-06-04","current":-7.666015,"twenty":-5.488323,"median":-2.782032,"eighty":-1.751353,"marketCap":167617412},{"date":"2021-06-11","current":-7.859974,"twenty":-5.488323,"median":-2.782032,"eighty":-1.751353,"marketCap":171858335},{"date":"2021-06-18","current":-7.416638,"twenty":-5.488323,"median":-2.782032,"eighty":-1.751353,"marketCap":162164798},{"date":"2021-06-25","current":-7.767613,"twenty":-5.488323,"median":-2.782032,"eighty":-1.751353,"marketCap":169838848},{"date":"2021-07-02","current":-7.084137,"twenty":-5.488323,"median":-2.782032,"eighty":-1.751353,"marketCap":154894645},{"date":"2021-07-09","current":-6.705454,"twenty":-5.488323,"median":-2.782032,"eighty":-1.751353,"marketCap":146614748},{"date":"2021-07-16","current":-6.631565,"twenty":-5.488323,"median":-2.782032,"eighty":-1.751353,"marketCap":144999159},{"date":"2021-07-23","current":-6.529967,"twenty":-5.488323,"median":-2.782032,"eighty":-1.751353,"marketCap":142777723},{"date":"2021-07-30","current":-6.381858,"twenty":-5.501619,"median":-2.782032,"eighty":-1.751353,"marketCap":142066551},{"date":"2021-08-06","current":-6.631,"twenty":-5.539494,"median":-2.782032,"eighty":-1.751353,"marketCap":147612692},{"date":"2021-08-13","current":-6.056058,"twenty":-5.590697,"median":-2.782032,"eighty":-1.751353,"marketCap":134813904},{"date":"2021-08-20","current":-5.778169,"twenty":-5.614629,"median":-2.782032,"eighty":-1.751353,"marketCap":128627823},{"date":"2021-08-27","current":-5.806916,"twenty":-5.640622,"median":-2.782032,"eighty":-1.751353,"marketCap":129267762},{"date":"2021-09-03","current":-6.084805,"twenty":-5.722321,"median":-2.782032,"eighty":-1.751353,"marketCap":135453843},{"date":"2021-09-10","current":-5.768587,"twenty":-5.785835,"median":-2.782032,"eighty":-1.751353,"marketCap":128414510},{"date":"2021-09-17","current":-7.502996,"twenty":-5.805755,"median":-2.782032,"eighty":-1.751353,"marketCap":167024188},{"date":"2021-09-24","current":-9.266152,"twenty":-5.825538,"median":-2.782032,"eighty":-1.751353,"marketCap":206273806},{"date":"2021-10-01","current":-8.221674,"twenty":-5.861923,"median":-2.782032,"eighty":-1.751353,"marketCap":183022674},{"date":"2021-10-08","current":-7.675478,"twenty":-5.872646,"median":-2.782388,"eighty":-1.751477,"marketCap":170863825},{"date":"2021-10-15","current":-7.704226,"twenty":-5.908489,"median":-2.782388,"eighty":-1.751477,"marketCap":171503764},{"date":"2021-10-22","current":-8.162229,"twenty":-5.955546,"median":-2.786754,"eighty":-1.751477,"marketCap":181699377},{"date":"2021-10-29","current":-7.766484,"twenty":-6.037658,"median":-2.799692,"eighty":-1.751477,"marketCap":172889710},{"date":"2021-11-05","current":-8.19191,"twenty":-6.083553,"median":-2.80245,"eighty":-1.751477,"marketCap":182360102},{"date":"2021-11-12","current":-7.586665,"twenty":-6.12087,"median":-2.817736,"eighty":-1.751477,"marketCap":175585778},{"date":"2021-11-19","current":-7.253499,"twenty":-6.156519,"median":-2.817736,"eighty":-1.751477,"marketCap":167874985},{"date":"2021-11-26","current":-6.939371,"twenty":-6.198706,"median":-2.820255,"eighty":-1.751477,"marketCap":160604809},{"date":"2021-12-03","current":-6.044583,"twenty":-6.219755,"median":-2.829029,"eighty":-1.751477,"marketCap":139895821},{"date":"2021-12-10","current":-6.520534,"twenty":-6.241046,"median":-2.833898,"eighty":-1.751477,"marketCap":150911240},{"date":"2021-12-17","current":-6.663319,"twenty":-6.265854,"median":-2.852054,"eighty":-1.751477,"marketCap":154215866},{"date":"2021-12-23","current":-6.339673,"twenty":-6.291084,"median":-2.855689,"eighty":-1.751477,"marketCap":146725381},{"date":"2021-12-31","current":-5.720936,"twenty":-6.291084,"median":-2.8711,"eighty":-1.751477,"marketCap":132405336},{"date":"2022-01-07","current":-5.854202,"twenty":-6.290587,"median":-2.879943,"eighty":-1.7516,"marketCap":135489653},{"date":"2022-01-14","current":-5.530555,"twenty":-6.290587,"median":-2.883827,"eighty":-1.7516,"marketCap":127999168},{"date":"2022-01-21","current":-5.09268,"twenty":-6.290587,"median":-2.913684,"eighty":-1.7516,"marketCap":117864983},{"date":"2022-01-28","current":-4.978452,"twenty":-6.290091,"median":-2.928404,"eighty":-1.751724,"marketCap":115221282},{"date":"2022-02-04","current":-4.911818,"twenty":-6.290091,"median":-2.936392,"eighty":-1.751724,"marketCap":113679124},{"date":"2022-02-11","current":-4.816628,"twenty":-6.290091,"median":-2.936392,"eighty":-1.751724,"marketCap":111476040},{"date":"2022-02-18","current":-4.835666,"twenty":-6.290091,"median":-2.936392,"eighty":-1.751724,"marketCap":111916657},{"date":"2022-02-25","current":-4.807109,"twenty":-6.290091,"median":-2.936392,"eighty":-1.751724,"marketCap":111255731},{"date":"2022-03-04","current":-4.730957,"twenty":-6.290091,"median":-2.936392,"eighty":-1.751724,"marketCap":109493264},{"date":"2022-03-11","current":-4.569133,"twenty":-6.290091,"median":-2.936392,"eighty":-1.751724,"marketCap":105748022},{"date":"2022-03-18","current":-4.845185,"twenty":-6.290091,"median":-2.936392,"eighty":-1.751724,"marketCap":112136965},{"date":"2022-03-25","current":-4.549642,"twenty":-6.290091,"median":-2.936392,"eighty":-1.751724,"marketCap":112712827},{"date":"2022-04-01","current":-4.585395,"twenty":-6.290091,"median":-2.936392,"eighty":-1.751724,"marketCap":113598586},{"date":"2022-04-08","current":-4.647964,"twenty":-6.290091,"median":-2.936392,"eighty":-1.751724,"marketCap":115148664},{"date":"2022-04-14","current":-6.078107,"twenty":-6.290091,"median":-2.936392,"eighty":-1.751724,"marketCap":150579023},{"date":"2022-04-22","current":-6.131737,"twenty":-6.296594,"median":-2.936392,"eighty":-1.751724,"marketCap":151907661},{"date":"2022-04-29","current":-5.345159,"twenty":-6.296594,"median":-2.936392,"eighty":-1.751724,"marketCap":132420964},{"date":"2022-05-06","current":-5.112761,"twenty":-6.296594,"median":-2.936392,"eighty":-1.751724,"marketCap":126663531},{"date":"2022-05-13","current":-5.563231,"twenty":-6.296594,"median":-2.936392,"eighty":-1.751724,"marketCap":136760909},{"date":"2022-05-20","current":-5.853487,"twenty":-6.296594,"median":-2.936392,"eighty":-1.751724,"marketCap":143896261},{"date":"2022-05-27","current":-5.447129,"twenty":-6.296594,"median":-2.936392,"eighty":-1.751724,"marketCap":133906768},{"date":"2022-06-03","current":-5.185899,"twenty":-6.296594,"median":-2.936392,"eighty":-1.751724,"marketCap":127484952},{"date":"2022-06-10","current":-4.914994,"twenty":-6.296594,"median":-2.936392,"eighty":-1.751724,"marketCap":120825290},{"date":"2022-06-17","current":-4.992395,"twenty":-6.296594,"median":-2.939684,"eighty":-1.751724,"marketCap":122728050},{"date":"2022-06-24","current":-4.944019,"twenty":-6.297837,"median":-2.93857,"eighty":-1.7516,"marketCap":121538825},{"date":"2022-07-01","current":-4.798891,"twenty":-6.297837,"median":-2.93857,"eighty":-1.7516,"marketCap":117971149},{"date":"2022-07-08","current":-5.050446,"twenty":-6.297837,"median":-2.941386,"eighty":-1.7516,"marketCap":124155121},{"date":"2022-07-15","current":-4.885968,"twenty":-6.297837,"median":-2.957708,"eighty":-1.7516,"marketCap":120111755},{"date":"2022-07-22","current":-4.682789,"twenty":-6.297837,"median":-2.982798,"eighty":-1.7516,"marketCap":115117009},{"date":"2022-07-29","current":-4.769866,"twenty":-6.297837,"median":-3.02078,"eighty":-1.7516,"marketCap":117257614},{"date":"2022-08-05","current":-5.543881,"twenty":-6.297837,"median":-3.040268,"eighty":-1.7516,"marketCap":136285219},{"date":"2022-08-12","current":-5.446277,"twenty":-6.297837,"median":-3.06668,"eighty":-1.7516,"marketCap":148841305},{"date":"2022-08-19","current":-5.418631,"twenty":-6.297837,"median":-3.084118,"eighty":-1.7516,"marketCap":148085765},{"date":"2022-08-26","current":-6.146644,"twenty":-6.297837,"median":-3.118224,"eighty":-1.7516,"marketCap":167981642},{"date":"2022-09-02","current":-7.335426,"twenty":-6.309848,"median":-3.142585,"eighty":-1.7516,"marketCap":200469845},{"date":"2022-09-09","current":-7.814624,"twenty":-6.317251,"median":-3.162074,"eighty":-1.7516,"marketCap":213565865},{"date":"2022-09-16","current":-7.353856,"twenty":-6.347186,"median":-3.184394,"eighty":-1.7516,"marketCap":200973538},{"date":"2022-09-23","current":-6.727212,"twenty":-6.375565,"median":-3.188508,"eighty":-1.7516,"marketCap":183847974},{"date":"2022-09-30","current":-6.800935,"twenty":-6.426974,"median":-3.264391,"eighty":-1.7516,"marketCap":185862746},{"date":"2022-10-07","current":-7.095826,"twenty":-6.466892,"median":-3.372124,"eighty":-1.7516,"marketCap":193921835},{"date":"2022-10-14","current":-6.81015,"twenty":-6.493464,"median":-3.432024,"eighty":-1.7516,"marketCap":186114593},{"date":"2022-10-21","current":-6.644274,"twenty":-6.514823,"median":-3.497692,"eighty":-1.7516,"marketCap":181581355},{"date":"2022-10-28","current":-8.966544,"twenty":-6.528686,"median":-3.556724,"eighty":-1.7516,"marketCap":245046683},{"date":"2022-11-04","current":-10.044741,"twenty":-6.545571,"median":-3.607395,"eighty":-1.7516,"marketCap":274512728},{"date":"2022-11-11","current":-10.9202,"twenty":-6.573735,"median":-3.676581,"eighty":-1.7516,"marketCap":298438149},{"date":"2022-11-18","current":-10.007105,"twenty":-6.621418,"median":-3.751613,"eighty":-1.7516,"marketCap":304015840},{"date":"2022-11-25","current":-9.227003,"twenty":-6.631226,"median":-3.851007,"eighty":-1.7516,"marketCap":280316366},{"date":"2022-12-02","current":-9.453484,"twenty":-6.646579,"median":-4.155392,"eighty":-1.7516,"marketCap":287196858},{"date":"2022-12-09","current":-9.034075,"twenty":-6.660035,"median":-4.496012,"eighty":-1.7516,"marketCap":274455205},{"date":"2022-12-16","current":-9.302497,"twenty":-6.679082,"median":-4.567519,"eighty":-1.7516,"marketCap":282609863},{"date":"2022-12-23","current":-8.421738,"twenty":-6.724542,"median":-4.587809,"eighty":-1.7516,"marketCap":255852392},{"date":"2022-12-30","current":-8.933417,"twenty":-6.753947,"median":-4.634413,"eighty":-1.7516,"marketCap":271397208},{"date":"2023-01-06","current":-8.287527,"twenty":-6.778375,"median":-4.653764,"eighty":-1.7516,"marketCap":251775063},{"date":"2023-01-13","current":-8.514008,"twenty":-6.80712,"median":-4.692464,"eighty":-1.7516,"marketCap":258655555},{"date":"2023-01-20","current":-9.227003,"twenty":-6.81015,"median":-4.72841,"eighty":-1.7516,"marketCap":280316366},{"date":"2023-01-27","current":-9.696742,"twenty":-6.841186,"median":-4.769866,"eighty":-1.7516,"marketCap":294587017},{"date":"2023-02-03","current":-10.241974,"twenty":-6.890177,"median":-4.79759,"eighty":-1.7516,"marketCap":311151166},{"date":"2023-02-10","current":-10.90464,"twenty":-6.916268,"median":-4.808567,"eighty":-1.755491,"marketCap":331282978},{"date":"2023-02-17","current":-11.542143,"twenty":-6.965611,"median":-4.818242,"eighty":-1.762031,"marketCap":350650290},{"date":"2023-02-24","current":-7.767459,"twenty":-7.019706,"median":-4.835666,"eighty":-1.778348,"marketCap":235975413},{"date":"2023-03-03","current":-8.497231,"twenty":-7.046348,"median":-4.884816,"eighty":-1.798523,"marketCap":258145889},{"date":"2023-03-10","current":-7.138345,"twenty":-7.08043,"median":-4.911818,"eighty":-1.80875,"marketCap":216862934},{"date":"2023-03-17","current":-7.784236,"twenty":-7.114972,"median":-4.933993,"eighty":-1.831633,"marketCap":236485079},{"date":"2023-03-24","current":-7.834565,"twenty":-7.149721,"median":-4.949894,"eighty":-1.842907,"marketCap":238014078},{"date":"2023-03-31","current":-7.926835,"twenty":-7.207328,"median":-4.990183,"eighty":-1.866152,"marketCap":240817241},{"date":"2023-04-06","current":-7.306109,"twenty":-7.239688,"median":-5.004539,"eighty":-1.891427,"marketCap":221959595},{"date":"2023-04-14","current":-7.691966,"twenty":-7.254508,"median":-5.040771,"eighty":-1.905611,"marketCap":233681916},{"date":"2023-04-21","current":-6.93556,"twenty":-7.254508,"median":-5.064123,"eighty":-1.925645,"marketCap":228991393},{"date":"2023-04-28","current":-6.834254,"twenty":-7.259978,"median":-5.09268,"eighty":-1.966075,"marketCap":225646574},{"date":"2023-05-05","current":-6.912182,"twenty":-7.259978,"median":-5.127848,"eighty":-1.993151,"marketCap":228219511},{"date":"2023-05-12","current":-6.452409,"twenty":-7.259978,"median":-5.159313,"eighty":-2.00625,"marketCap":213039183},{"date":"2023-05-19","current":-5.532558,"twenty":-7.259978,"median":-5.225075,"eighty":-2.02033,"marketCap":215354826},{"date":"2023-05-26","current":-5.597458,"twenty":-7.259978,"median":-5.238371,"eighty":-2.043298,"marketCap":217881064},{"date":"2023-06-02","current":-5.658521,"twenty":-7.261956,"median":-5.25221,"eighty":-2.054966,"marketCap":220257948},{"date":"2023-06-09","current":-5.88242,"twenty":-7.263934,"median":-5.28259,"eighty":-2.061028,"marketCap":228973191},{"date":"2023-06-16","current":-5.251434,"twenty":-7.263934,"median":-5.321351,"eighty":-2.082067,"marketCap":204412053},{"date":"2023-06-23","current":-5.475332,"twenty":-7.265912,"median":-5.34293,"eighty":-2.081273,"marketCap":213127295},{"date":"2023-06-30","current":-4.851131,"twenty":-7.265912,"median":-5.345159,"eighty":-2.079954,"marketCap":188830255},{"date":"2023-07-07","current":-4.966472,"twenty":-7.265912,"median":-5.345159,"eighty":-2.079954,"marketCap":193319926},{"date":"2023-07-14","current":-4.851131,"twenty":-7.265912,"median":-5.345159,"eighty":-2.079954,"marketCap":188830255},{"date":"2023-07-21","current":-4.891839,"twenty":-7.265912,"median":-5.345159,"eighty":-2.079954,"marketCap":190414845},{"date":"2023-07-28","current":-4.688295,"twenty":-7.265912,"median":-5.345159,"eighty":-2.079954,"marketCap":182491897},{"date":"2023-08-04","current":-4.661156,"twenty":-7.265912,"median":-5.345159,"eighty":-2.079954,"marketCap":181435504},{"date":"2023-08-11","current":-4.464397,"twenty":-7.265912,"median":-5.345159,"eighty":-2.079954,"marketCap":173776655},{"date":"2023-08-18","current":-3.583054,"twenty":-7.265912,"median":-5.345159,"eighty":-2.079954,"marketCap":166035160},{"date":"2023-08-25","current":-3.484011,"twenty":-7.265912,"median":-5.345159,"eighty":-2.079954,"marketCap":161445570},{"date":"2023-09-01","current":-3.501489,"twenty":-7.265912,"median":-5.345159,"eighty":-2.079954,"marketCap":162255497},{"date":"2023-09-08","current":-3.752011,"twenty":-7.265912,"median":-5.345159,"eighty":-2.079954,"marketCap":173864460},{"date":"2023-09-15","current":-3.87436,"twenty":-7.265912,"median":-5.345159,"eighty":-2.079954,"marketCap":179533953},{"date":"2023-09-22","current":-3.66462,"twenty":-7.265912,"median":-5.345159,"eighty":-2.079954,"marketCap":169814822},{"date":"2023-09-29","current":-3.588881,"twenty":-7.265912,"median":-5.345159,"eighty":-2.079954,"marketCap":166305135},{"date":"2023-10-06","current":-3.542272,"twenty":-7.265912,"median":-5.351594,"eighty":-2.078635,"marketCap":164145328},{"date":"2023-10-13","current":-3.460706,"twenty":-7.265912,"median":-5.351594,"eighty":-2.078635,"marketCap":160365666},{"date":"2023-10-20","current":-3.355836,"twenty":-7.265912,"median":-5.351594,"eighty":-2.078635,"marketCap":155506101},{"date":"2023-10-27","current":-3.227662,"twenty":-7.265912,"median":-5.358029,"eighty":-2.074677,"marketCap":149566631},{"date":"2023-11-03","current":-2.466025,"twenty":-7.265912,"median":-5.358029,"eighty":-2.074677,"marketCap":123648948},{"date":"2023-11-10","current":-2.553215,"twenty":-7.265912,"median":-5.358029,"eighty":-2.074677,"marketCap":128020769},{"date":"2023-11-17","current":-2.482141,"twenty":-7.265912,"median":-5.358029,"eighty":-2.074677,"marketCap":124457022},{"date":"2023-11-24","current":-2.438403,"twenty":-7.265912,"median":-5.358029,"eighty":-2.074677,"marketCap":122263946},{"date":"2023-12-01","current":-2.50401,"twenty":-7.265912,"median":-5.358029,"eighty":-2.074677,"marketCap":125553559},{"date":"2023-12-08","current":-2.897653,"twenty":-7.265912,"median":-5.358029,"eighty":-2.075996,"marketCap":145291237},{"date":"2023-12-15","current":-2.782841,"twenty":-7.265912,"median":-5.358029,"eighty":-2.075996,"marketCap":139534414},{"date":"2023-12-22","current":-2.618823,"twenty":-7.265912,"median":-5.358029,"eighty":-2.097526,"marketCap":131310382},{"date":"2023-12-29","current":-2.733635,"twenty":-7.265912,"median":-5.358029,"eighty":-2.124592,"marketCap":137067205},{"date":"2024-01-05","current":-2.853915,"twenty":-7.266502,"median":-5.358029,"eighty":-2.143272,"marketCap":143098162},{"date":"2024-01-12","current":-2.826579,"twenty":-7.266502,"median":-5.358029,"eighty":-2.143272,"marketCap":141727489},{"date":"2024-01-19","current":-2.733635,"twenty":-7.267091,"median":-5.358029,"eighty":-2.138602,"marketCap":137067205},{"date":"2024-01-26","current":-2.86485,"twenty":-7.266502,"median":-5.358029,"eighty":-2.143272,"marketCap":143646430},{"date":"2024-02-02","current":-3.039802,"twenty":-7.266502,"median":-5.358029,"eighty":-2.143272,"marketCap":152418731},{"date":"2024-02-09","current":-2.851674,"twenty":-7.266502,"median":-5.358029,"eighty":-2.143272,"marketCap":142985799},{"date":"2024-02-16","current":-3.255892,"twenty":-7.266502,"median":-5.358029,"eighty":-2.143272,"marketCap":163253690},{"date":"2024-02-23","current":-3.732094,"twenty":-7.266502,"median":-5.358029,"eighty":-2.143272,"marketCap":187130930},{"date":"2024-03-01","current":-4.723259,"twenty":-7.265912,"median":-5.358029,"eighty":-2.147942,"marketCap":236828907},{"date":"2024-03-08","current":-4.213833,"twenty":-7.265912,"median":-5.358029,"eighty":-2.147942,"marketCap":211285813},{"date":"2024-03-15","current":-3.471844,"twenty":-7.265912,"median":-5.358029,"eighty":-2.147942,"marketCap":174081740},{"date":"2024-03-22","current":-5.044418,"twenty":-7.265912,"median":-5.358029,"eighty":-2.147942,"marketCap":252932162},{"date":"2024-03-28","current":-4.396562,"twenty":-7.265912,"median":-5.358029,"eighty":-2.147942,"marketCap":220448010},{"date":"2024-04-05","current":-5.497751,"twenty":-7.266502,"median":-5.358029,"eighty":-2.143272,"marketCap":268389232},{"date":"2024-04-12","current":-5.473665,"twenty":-7.266502,"median":-5.381721,"eighty":-2.143272,"marketCap":267213375},{"date":"2024-04-19","current":-4.01643,"twenty":-7.266502,"median":-5.384329,"eighty":-2.165076,"marketCap":196074061},{"date":"2024-04-26","current":-3.950192,"twenty":-7.265912,"median":-5.38404,"eighty":-2.285319,"marketCap":192840456},{"date":"2024-05-03","current":-5.610325,"twenty":-7.265912,"median":-5.384619,"eighty":-2.317135,"marketCap":260605196},{"date":"2024-05-10","current":-5.706502,"twenty":-7.265912,"median":-5.393914,"eighty":-2.369797,"marketCap":265072713},{"date":"2024-05-17","current":-6.315623,"twenty":-7.265912,"median":-5.409317,"eighty":-2.438403,"marketCap":293366992},{"date":"2024-05-24","current":-5.398735,"twenty":-7.265912,"median":-5.418631,"eighty":-2.471635,"marketCap":250776657},{"date":"2024-05-31","current":-5.19997,"twenty":-7.265912,"median":-5.41947,"eighty":-2.487608,"marketCap":241543787},{"date":"2024-06-07","current":-5.123028,"twenty":-7.265912,"median":-5.424506,"eighty":-2.50401,"marketCap":237969773},{"date":"2024-06-14","current":-5.142263,"twenty":-7.266502,"median":-5.425176,"eighty":-2.545152,"marketCap":238863277},{"date":"2024-06-21","current":-4.840909,"twenty":-7.267091,"median":-5.425846,"eighty":-2.609077,"marketCap":224865055},{"date":"2024-06-28","current":-4.73832,"twenty":-7.26886,"median":-5.446277,"eighty":-2.646159,"marketCap":220099702},{"date":"2024-07-05","current":-4.66779,"twenty":-7.26886,"median":-5.446277,"eighty":-2.721782,"marketCap":216823523},{"date":"2024-07-12","current":-4.731908,"twenty":-7.26886,"median":-5.446277,"eighty":-2.760972,"marketCap":219801868},{"date":"2024-07-15","current":-4.776791,"twenty":-7.26886,"median":-5.446277,"eighty":-2.766106,"marketCap":221886709},{"date":"2024-08-02","current":-4.244611,"twenty":-7.27988,"median":-5.464392,"eighty":-2.838607,"marketCap":197166445},{"date":"2024-08-09","current":-1.761538,"twenty":-7.27988,"median":-5.464392,"eighty":-2.849738,"marketCap":75082046},{"date":"2024-08-16","current":-1.425311,"twenty":-7.27988,"median":-5.464392,"eighty":-2.849738,"marketCap":60751033},{"date":"2024-08-23","current":-1.491095,"twenty":-7.27988,"median":-5.464392,"eighty":-2.849738,"marketCap":63554927},{"date":"2024-08-30","current":-1.396074,"twenty":-7.27988,"median":-5.464392,"eighty":-2.849738,"marketCap":59504858},{"date":"2024-09-06","current":-1.257197,"twenty":-7.27988,"median":-5.464392,"eighty":-2.849738,"marketCap":53585526},{"date":"2024-09-13","current":-1.43262,"twenty":-7.27988,"median":-5.464392,"eighty":-2.849738,"marketCap":61062576},{"date":"2024-09-20","current":-1.374146,"twenty":-7.27988,"median":-5.464392,"eighty":-2.849738,"marketCap":58570226},{"date":"2024-09-27","current":-1.308362,"twenty":-7.27988,"median":-5.464392,"eighty":-2.849738,"marketCap":55766333},{"date":"2024-10-04","current":-1.301053,"twenty":-7.27988,"median":-5.464392,"eighty":-2.849738,"marketCap":55454789},{"date":"2024-10-11","current":-1.191414,"twenty":-7.27988,"median":-5.464392,"eighty":-2.849738,"marketCap":50781632},{"date":"2024-10-18","current":-1.257197,"twenty":-7.27988,"median":-5.464392,"eighty":-2.849738,"marketCap":53585526},{"date":"2024-10-25","current":-1.22796,"twenty":-7.27988,"median":-5.464392,"eighty":-2.849738,"marketCap":52339351},{"date":"2024-10-31","current":-1.301053,"twenty":-7.27988,"median":-5.464392,"eighty":-2.849738,"marketCap":55454789},{"date":"2024-11-08","current":-1.3376,"twenty":-7.282868,"median":-5.464392,"eighty":-2.852013,"marketCap":57012508},{"date":"2024-11-15","current":-1.258053,"twenty":-7.282868,"median":-5.464392,"eighty":-2.852013,"marketCap":51473220},{"date":"2024-11-22","current":-1.12081,"twenty":-7.282868,"median":-5.464392,"eighty":-2.852013,"marketCap":45857959},{"date":"2024-11-29","current":-1.097937,"twenty":-7.282868,"median":-5.464392,"eighty":-2.852013,"marketCap":44922083},{"date":"2024-12-06","current":-0.930196,"twenty":-7.282868,"median":-5.464392,"eighty":-2.852013,"marketCap":38058987},{"date":"2024-12-13","current":-0.95307,"twenty":-7.282868,"median":-5.464392,"eighty":-2.852013,"marketCap":38994863},{"date":"2024-12-20","current":-0.853951,"twenty":-7.282868,"median":-5.464392,"eighty":-2.852013,"marketCap":34939397},{"date":"2024-12-27","current":-0.983568,"twenty":-7.282868,"median":-5.464392,"eighty":-2.852013,"marketCap":40242699},{"date":"2025-01-03","current":-0.960695,"twenty":-7.282868,"median":-5.464392,"eighty":-2.852013,"marketCap":39306822},{"date":"2025-01-10","current":-0.998817,"twenty":-7.285855,"median":-5.464392,"eighty":-2.853369,"marketCap":40866617},{"date":"2025-01-17","current":-0.930196,"twenty":-7.285855,"median":-5.464392,"eighty":-2.853369,"marketCap":38058987},{"date":"2025-01-24","current":-1.021691,"twenty":-7.285855,"median":-5.464392,"eighty":-2.853369,"marketCap":41802493},{"date":"2025-01-31","current":-0.930196,"twenty":-7.285855,"median":-5.464392,"eighty":-2.853369,"marketCap":38058987},{"date":"2025-02-07","current":-0.876824,"twenty":-7.285855,"median":-5.464392,"eighty":-2.853369,"marketCap":35875274},{"date":"2025-02-14","current":-0.838702,"twenty":-7.285855,"median":-5.464392,"eighty":-2.853369,"marketCap":34315480},{"date":"2025-02-21","current":-0.937821,"twenty":-7.285855,"median":-5.464392,"eighty":-2.853369,"marketCap":38370945},{"date":"2025-02-28","current":-0.838702,"twenty":-7.285855,"median":-5.464392,"eighty":-2.853369,"marketCap":34315480},{"date":"2025-03-07","current":-0.8692,"twenty":-7.286554,"median":-5.465435,"eighty":-2.853806,"marketCap":35563315},{"date":"2025-03-14","current":-0.914947,"twenty":-7.286554,"median":-5.465435,"eighty":-2.853806,"marketCap":37435069},{"date":"2025-03-21","current":-1.075063,"twenty":-7.286554,"median":-5.465435,"eighty":-2.853806,"marketCap":43986206},{"date":"2025-03-28","current":-1.441042,"twenty":-7.286554,"median":-5.465435,"eighty":-2.853806,"marketCap":58960233},{"date":"2025-04-04","current":-1.133862,"twenty":-7.286554,"median":-5.465435,"eighty":-2.853806,"marketCap":43362288},{"date":"2025-04-11","current":-0.938087,"twenty":-7.285855,"median":-5.464392,"eighty":-2.853369,"marketCap":35875274},{"date":"2025-04-17","current":-1.01966,"twenty":-7.285855,"median":-5.464392,"eighty":-2.853369,"marketCap":38994863},{"date":"2025-04-25","current":-1.035975,"twenty":-7.286554,"median":-5.465435,"eighty":-2.853806,"marketCap":39618781},{"date":"2025-05-02","current":-1.215435,"twenty":-7.286554,"median":-5.465435,"eighty":-2.853806,"marketCap":46481877},{"date":"2025-05-09","current":-1.166491,"twenty":-7.286554,"median":-5.465435,"eighty":-2.853806,"marketCap":44610124},{"date":"2025-05-16","current":-1.048751,"twenty":-7.286554,"median":-5.465435,"eighty":-2.853806,"marketCap":47729713},{"date":"2025-05-23","current":-1.165279,"twenty":-7.286554,"median":-5.465435,"eighty":-2.853806,"marketCap":53033014},{"date":"2025-05-30","current":-1.083024,"twenty":-7.286554,"median":-5.465435,"eighty":-2.851029,"marketCap":49289507},{"date":"2025-06-06","current":-1.158424,"twenty":-7.286554,"median":-5.465435,"eighty":-2.826061,"marketCap":52721055},{"date":"2025-06-13","current":-1.089879,"twenty":-7.286554,"median":-5.458627,"eighty":-2.778467,"marketCap":49601466},{"date":"2025-06-20","current":-1.000769,"twenty":-7.287253,"median":-5.446277,"eighty":-2.733635,"marketCap":45546000},{"date":"2025-06-27","current":-1.110442,"twenty":-7.267091,"median":-5.417858,"eighty":-2.646159,"marketCap":50537343}],"updateTime":1751209956831}}}